Massachusetts Financial Services
IMMU

Massachusetts Financial Services’s Immunomedics Inc IMMU Stock Holding History

Massachusetts Financial Services’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-478,944
Closed -$17M – 919
2020
Q2 		$17M Buy
478,944
+18,654
+4% +$545K 0.01% 565
2020
Q1 		$6.21M Sell
460,290
-10,659
-2% -$179K ﹤0.01% 624
2019
Q4 		$9.96M Buy
470,949
+143
+0% +$2.52K ﹤0.01% 607
2019
Q3 		$6.24M Sell
470,806
-1,809
-0.4% -$26.6K ﹤0.01% 642
2019
Q2 		$6.55M Buy
472,615
+2,735
+0.6% +$41.2K ﹤0.01% 651
2019
Q1 		$9.03M Sell
469,880
-96,504
-17% -$1.56M ﹤0.01% 622
2018
Q4 		$8.08M Buy
566,384
+11,554
+2% +$229K ﹤0.01% 625
2018
Q3 		$11.6M Sell
554,830
-84
-0% -$1.99K ﹤0.01% 604
2018
Q2 		$13.1M Buy
554,914
+7,694
+1% +$155K 0.01% 591
2018
Q1 		$8M Buy
+547,220
New +$8.94M ﹤0.01% 640

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Massachusetts Financial Services's IMMU Position: Q3 2020 in Review

Massachusetts Financial Services sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 478,944 shares — an estimated $17M sold.

Massachusetts Financial Services first reported a position in IMMU in Q1 2018 and held it in 10 quarters. The position peaked at $17M in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Massachusetts Financial Services reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Massachusetts Financial Services sold 478,944 Immunomedics Inc shares in Q3 2020, an estimated $17M.
  • Massachusetts Financial Services first reported a position in Immunomedics Inc in Q1 2018 and held it in 10 quarters.
  • Massachusetts Financial Services's Immunomedics Inc position peaked at $17M in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Massachusetts Financial Services's 13F filing for Q3 2020, filed 12 Nov 2020.